Urograffin for adhesive small bowel obstruction in Ethiopia

Urograffin protocol for the management of adhesive small bowel obstruction: examining the impact on patient outcomes and cost.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406577620935

Enrollment

Registered

2024-06-04

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Surgery

Interventions

Urograffin protocol

Standard care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All adults (>18) admitted with adhesive small bowel obstruction as diagnosed by clinical and/or radiographic criteria: - Abdominal distension - Nausea, vomiting - Abdominal pain - Obstipation or constipation - History of prior abdominopelvic surgery or intraabdominal infection - +/- radiographic findings of dilated small bowel and/or air fluid levels

Exclusion criteria

Exclusion criteria: - Age <18 - Any concern for bowel strangulation including peritonitis, acidosis, marked leukocytosis, worsening abdominal pain, or other concerns of clinical team – patient indicated for immediate operation - Any concern for large bowel obstruction - Current intraabdominal malignancy - History of abdominal radiation - Diagnosis of inflammatory bowel disease

Design outcomes

Primary

Measure	Time frame
Completion of urograffin protocol	—

Secondary

Measure	Time frame
Proportion of patients requiring surgery ;Hospital length of stay ;Cost of hospitalization ;Aspiration pneumonia	—

Countries

Ethiopia

Contacts

Public ContactMekdim Tadesse

Assistant Professor St. Paul Millennium Medical College

mekdimts@yahoo.com251917800415

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026